Diality Raises $28 Million To Support Continued Regulatory, Clinical And Commercial Initiatives For Its User Friendly, Mobile And Connected Hemodialysis System With Category Leading Prescription Range
Aug 09, 2023•over 2 years ago
Amount Raised
$28 Million
Description
Diality Inc., a medical technology company developing a user friendly, mobile and connected hemodialysis system with a category leading prescription range, today announced the closing of a $28 million investment round. The funding will be used to support Diality’s 510(k) filing and pre-commercialization activities through initial commercial launch targeting hospitals, skilled nursing facilities, and de novo clinics. The funding will also support initiation and early enrollment of Diality’s U.S. home hemodialysis clinical trial.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech